Author

R. Qiao

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 5 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 6 Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1

Frequent Co-Authors

M. Li· 5 shared P. Wang· 5 shared W. Zhang· 5 shared X. Wang· 5 shared X. Zhao· 5 shared Y. Chen· 5 shared Y. Cui· 5 shared Z. Hu· 5 shared

Activity by Year

2022-2024 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersImmunology

M. Li

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination

X. Zhao, T. Qiu, X. Huang, Q. Mao, Y. Wang, R. Qiao, T. Mao, Y. Wang, J. Li, C. Luo, C. Yoon, X. Wang, C. Li, Y. Cui, C. Zhao, , P. Wang

This study identifies potent and broadly neutralizing antibodies against SARS-CoV-2 and related sarbecoviruses from a vaccinated donor, showing their efficacy against multiple variants and providing insights for therapeutic development.

Cell Discovery · Feb 6, 2024Peer-reviewedImmunology

M1 Macrophage-Related Genes Model for NSCLC Immunotherapy Response Prediction

S. Wu, Q. Sheng, P. Liu, Z. Jiao, J. Lv, R. Qiao, D. Xie, Z. Wang, J. Ge, P. Li, T. Wei, J. Lei, J. Fan, L. Wang

This study develops a model using M1 macrophage-related genes to predict immunotherapy response and prognosis in advanced NSCLC patients.

bioRxiv · Oct 21, 2023Immunology

Enhanced neutralization of SARS-CoV-2 XBB sub-lineages and BA.2.86 by a tetravalent COVID-19 vaccine booster

X. Wang, S. Jiang, W. Ma, X. Li, K. Wei, F. Xie, C. Zhao, X. Zhao, C. Li, R. Qiao, Y. Cui, Y. Chen, J. Li, G. Cai, C. Liu, , P. Wang

This study evaluates the neutralization efficacy of a tetravalent vaccine booster against emerging SARS-CoV-2 variants, finding it induces higher neutralizing titers than breakthrough infection.

bioRxiv · Sep 14, 2023 · PreprintImmunology

Neutralization of SARS-CoV-2 BQ.1.1 and XBB.1.5 by Breakthrough Infection Sera from Previous and Current Waves in China

X. Wang, S. Jiang, S. Jiang, X. Li, J. Ai, K. Lin, S. Lv, S. Zhang, M. Li, X. He, D. Li, C. Li, C. Zhao, X. Zhao, R. Qiao, , P. Wang

This study assesses neutralization of SARS-CoV-2 Omicron subvariants by sera from different vaccination and breakthrough infection cohorts, finding that BQ.1.1 and XBB.1.5 show strong neutralization evasion.

bioRxiv · Feb 7, 2023 · PreprintImmunology

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by Booster Vaccination or BA.2 Breakthrough Infection Sera

X. Wang, J. Ai, X. Li, X. Zhao, J. Wu, H. Zhang, X. He, C. Zhao, R. Qiao, M. Li, Y. Cui, Y. Chen, L. Yang, Z. Hu, C. Xu, , P. Wang

This study evaluates neutralization of Omicron sub-lineages by booster vaccination or BA.2 breakthrough infection sera using a pseudovirus panel.

bioRxiv · Aug 4, 2022Immunology

Antibody Resistance of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2 and BA.3 Sub-lineages

J. Ai, X. Wang, X. He, X. Zhao, Y. Zhang, Y. Jiang, M. Li, Y. Cui, Y. Chen, R. Qiao, L. Li, L. Yang, Y. Li, Z. Hu, W. Zhang, P. Wang

This study compares antibody neutralization efficacy against SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, BA.2, and BA.3, showing increased resistance and the benefit of vaccine boosters.

bioRxiv · Apr 7, 2022 · PreprintMicrobiology